Medspa meets primary care: The gateway to concierge medicine

October 25, 2025

by a searcher from Gonzaga University in Bend, OR, USA

I’ve been thinking a lot about where primary care, medspas, and concierge medicine are heading—and more importantly, where they intersect. Wrote up a working thesis on how medspas could become the cultural and commercial gateway to mainstream concierge medicine. The short version: patients are getting more health data than ever (Function, Superpower), but nowhere to actually act on it. Meanwhile, medspas already have the trust, the cash-pay models, and the consumer marketing chops that traditional healthcare never figured out. The convergence feels inevitable: aesthetics → wellness → primary care. If anyone here is thinking about this space or has been looking at deals in medspa, primary care, or the concierge medicine market, I’d love to hear your thoughts or compare notes. Working thesis: https://docs.google.com/document/d/1E9ex160b5VOGXpcCcXlJEtvEzTKRGXK4pJH5n8RtEaQ/edit?usp=sharing Reach out: redacted Cheers, Alex

Reply by a searcher
in Denver, CO, USA

Really interesting take. From what I’m seeing, the biologics supply chain is quietly becoming the infrastructure behind this convergence. These treatments: exosomes, peptides, regenerative biologics are exploding in adoption, and medspas are increasingly becoming a natural entry point into more structured wellness and concierge-style care. But I’m not sure medspas themselves capture the real growth, it feels more like a mix-shift than a volume story, with higher-ticket biologic treatments replacing older services rather than expanding the market. Bigger play may be in coordinating that supply chain, standardizing how biologics are sourced, delivered, and integrated. Whoever builds that bridge for aesthetics and functional medicine could end up owning the backbone of the next wave in consumer health in my opinion. It’s still looks to be the wild wild west right now, fragmented vendors or direct to manufacturer, little standardization, and tons of experimentation.

Reply by a searcher
from Rockhurst University in Danville, CA, USA

Interesting thought. But, as a physician, I don't see the convergence happening. Much of the wellness industry is not backed by evidence-based science. There's a reason why most primary care physicians will refuse to look at the slew of biomarkers you might have tested through Function Health or Superpower etc. They don't know what to do with it because the results are not clearly tied to clinical relevance. Just because you can test for something doesn't mean you should, if there is no significant data behind what to do with those results. Otherwise, you end up treating numbers rather than the patient, and optimizing biomarkers for the sake of optimizing biomarkers. Medspas don't need to worry about evidence-based medicine - they are purely a vanity play. But, when you start to blur the lines between vanity and health, most conscientious physicians are going to have a problem (or at least should), no matter how lucrative the opportunity.

+12 more replies.

Join the discussion